The DRS was ranked 1st for performance by the Centre for Eye Research Australia [...]
L’azienda opera nel campo della diagnostica precoce delle malattie degli [...]
When it comes to retinal diseases, such as diabetic retinopathy, early detection [...]
l 4 percento della popolazione mondiale soffre di diabete. Sono circa tre [...]
CenterVue annuncia la sua partecipazione all’Italian Innovation Day, un [...]CenterVue was established in 2008 with the support of M31, a European venture incubator with headquarters in Italy and operations in Silicon Valley, CA. M31 is active in the medical equipment, optical technologies, embedded systems, and wireless spaces.
CenterVue integrates the most advanced technologies to develop superior diagnostic instruments for eye care; the competences of CenterVue’s design team span highly specialized fields such as optical design, image processing and computer vision software, microelectronics design, industrial design, patient-machine interface.
CenterVue’s solutions integrate seamlessly with state-of-the art telemedicine packages.
The sound and synergistic collaboration that CenterVue enjoys with its parent company, M31, resulted in leading edge products.
A privately owned company, CenterVue combines the agility of a startup with the solid structure of an established organization: it features in-house research, product development, quality management and regulatory affairs, marketing, sales and post sales assistance.
Its strengths lie in its intellectual property and in the 120 men year of industry experience of its executives and researchers.
Saving your sight is our vision. Our goal is to reduce preventable blindness by means of early detection of sight-threatening diseases.
CenterVue enables large-scale screening programs that make early detection easy thanks to affordable ocular screening devices that are fully automated and web connected.
Giuliano Barbaro, CEO
Aldo Cocchiglia, President
Cliff Wright, COO
Stefano Gallucci, Co-CEO